Many in extra vulnerable patient cohorts, like those with heart disease and diabetes, don't realize they're at elevated risk of experiencing severe disease. What can doctors and pharmacists do to help?
Stress urinary incontinence can erode confidence, diminish social lives, decrease willingness to exercise and create a financial burden buying continence supplies.
With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.